You are here:
Home
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers
Epcoritamab for treating relapsed or refractory diffuse large B-cell lymphoma after first-line systemic treatment [ID6463]
Awaiting development
Reference number:
GID-TA11590
Expected publication date: TBC
Project information
Project documents
38344-Epcoritamab-for-Large-B-Cell-Lymphoma-V1.0-MAY2024-NON-CONF.pdf (nihr.ac.uk)
Back to top